European Companies Search Engine

17 EU fundings (total €7,271,320): 101045949 - XVR011 Phase 2 - Exevir's XVR011, a Best in Class Nanobody-Based Biology That Broadly Neutralizes Sars-COV-1 and Sars-COV-2 … BdlYear 2021 Financial Transparency System

Text

Vlaams Instituut Voor Biotechnologie - Flanders Institute for Biotechnology VZW, Ghent, Belgium

01/02/2021 EU funding (€1,499,327): 949808 - Cosi - Understanding Organelle Communication through Contact Sites in Plant Stress Responses
01/10/2021 EU funding (€12M): 101046203 - by-Covid - Beyond Covid Aims to Provide Comprehensive Open Data on Sars-COV-2, and Other Infectious Diseases Across Scientific, Medical, Public Health and Policy Domains
01/01/2021 EU funding (€150,000): 959109 - Superyeast - Generating Superior Industrial Yeasts through Modulation of Crabtree Repression
01/01/2021 EU funding (€150,000): 963639 - Target_Synaptic_TAU - Targeting TAU-Induced Cognitive Decline with Antisense Oligonucleotides to Synaptogyrin-3
01/01/2021 EU funding (€150,000): 963884 - Enhancerdesign - AI-Driven Enhancer Design for Gene Therapy
01/04/2021 EU funding (€166,320): 101027317 - Mactivate - Understanding Hepatic Macrophage Activation by Microbes and Microbial Components in Vivo
01/04/2021 EU funding (€166,320): 101027833 - Mafldcs - Elucidating Dendritic Cell Heterogeneity and Functions in Metabolic Associated Fatty Liver Disease
01/05/2021 EU funding (€166,320): 101030055 - Liver ID3Ntity - Unravelling the Molecular Basis of the Kupffer Cell-Hepatocyte Crosstalk and ITS Role in the Functional Specialization of Liver Kupffer Cells.
01/08/2021 EU funding (€166,320): 101032183 - Economy - Endothelial Cells - an Overlooked NON-Hematopoietic Component of Tumor Immunity
01/11/2021 EU funding (€178,320): 101030640 - Thacsis - Thalamic Control of Sensory Information Selection
01/09/2021 EU funding (€178,320): 885979 - Division Bell - the Role of Tetraspanins in Plant Cell Division Orientation
01/12/2021 EU funding (€2,499,497): 101020617 - Neurotempo - Controlling the Timing of Human Cortical Neuron Development: From Upstream Mechanisms to Impact on Circuit Plasticity.
01/01/2021 EU funding (€2,856,013): 955643 - Bioinspiresensing - Multidisciplinary Training of Young Researchers in Novel Implantable BIO-Inspired Sensors
01/01/2021 EU funding (€3,917,904): 956148 - Protrein - Computational Proteomics Training European Innovative Network
01/12/2021 EU funding (€316,762): 101045949 - XVR011 Phase 2 - Exevir's XVR011, a Best in Class Nanobody-Based Biology That Broadly Neutralizes Sars-COV-1 and Sars-COV-2
01/05/2021 EU funding (€7,905,559): 101000373 - Inncocells - Innovative High-Value Cosmetic Products From Plants and Plant Cells
01/01/2021 EU funding (€899,741): 952334 - Phasage - Excellence Hub on Phase Transitions in Aging and AGE-Related Disorders

This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Vlaams Instituut Voor Biotechnologie - Flanders Institute for Biotechnology VZW, Ghent, Belgium.

Creative Commons License The visualizations for "Vlaams Instituut Voor Biotechnologie - Flanders Institute for Biotechnology VZW - 17 EU fundings (total €7,271,320): 101045949 - XVR011 Phase 2 - Exevir's XVR011, a Best in Class Nanobody-Based Biology That Broadly Neutralizes Sars-COV-1 and Sars-COV-2 …" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.